Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Journal of leukocyte biology, 2012-12, Vol.92 (6), p.1187-1197
Ort / Verlag
United States: Society for Leukocyte Biology
Erscheinungsjahr
2012
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
Review of preclinical and clinical evidence implicating Th17 cells in psoriasis, and the therapeutic approaches to target this pathway.
In recent years, the classic paradigm of Th1/Th2 CD4+ T cell‐mediated immunity has evolved to include the IL‐17A‐producing Th17 subset, a distinct proinflammatory CD4+ T cell lineage. Accumulating evidence suggests that IL‐17A and the Th17 pathway may play an important role in the pathology of psoriasis and in other immune‐mediated inflammatory diseases. This review summarizes the preclinical and clinical evidence implicating Th17 cells in psoriasis and the therapeutic approaches, approved or under investigation, to target this pathway in psoriasis.